RecruitingNot ApplicableNCT06803199

Effects of LH and FSH on Metabolic Regulation in Cumulus Cells

Investigation of the Combined Effects of Luteinizing Hormone and Follicle-Stimulating Hormone on Metabolic Regulation in Cumulus Cells


Sponsor

Kaohsiung Veterans General Hospital.

Enrollment

60 participants

Start Date

Dec 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The combined use of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) has improved IVF pregnancy rates in infertile women aged 35-40, but its mechanisms remain unclear. This prospective study will examine how FSH and LH combined treatment affects cumulus cell energy metabolism. Sixty participants will be divided into two groups receiving either combined therapy or FSH alone. The study will analyze patient characteristics, infertility history, and compare mitochondrial function in cumulus cells to evaluate treatment effectiveness.


Eligibility

Sex: FEMALEMin Age: 35 YearsMax Age: 40 Years

Inclusion Criteria3

  • Age 35-40 years
  • BMI 18-30 kg/m2
  • planning to undergo IVF cycles

Exclusion Criteria8

  • Primary ovarian insufficiency
  • history of oophorectomy
  • receiving oocyte donation
  • Chromosome anomaly
  • Congenital uterine anomaly
  • Severe intrauterine adhesion
  • Malignancy
  • Using hormone therapy or supplements in recent 3 months

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFSH and LH

In the study group, participants receive FSH and LH in IVF cycle

DRUGFSH

In the control group, participants receive FSH alone in IVF cycle


Locations(1)

Kaohsiung Veterans General Hospital

Kaohsiung City, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06803199


Related Trials